7H-Pyrrolo[2,3-d]pyrimidine-5-carboxylic acid, 95.0%, 1g

3,5-Dibromobenzaldehyde>97.0%(GC)5g

Balance d'analyse et de précision série Entris® II Modèles avec réglage interne, non certifiée, 0,01 g, 1200 g, BCE1202i-1S

2-(Naphth-1-yl)acetamide oxime, 95.0%, 1g

2-Chloro-1-(4-phenylpiperazin-1-yl)ethanone, 95.0%, 1g

6-hydroxy-1,3-dimethyl-4-sulfanylidene-1,2,3,4-tetrahydropyrimidin-2-one, 97%, 500mg

2-(4-(Benzyloxy)-2-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

MOGUISTEINE, 97%, 500mg

Methyl benzo[d][1,3]dioxole-4-carboxylate, 95.0%, 100mg

Tetraisocyanatosilane>97.0%(N)5g

4-BROMO-1,3-DIHYDRO-BENZO[C]THIOPHENE 2,2-DIOXIDE, 95.0%, 1g

2-(4-Amino-2-nitrophenyl)acetic acid, 98%, 250mg

N-Hydroxysuccinimide, 98.0%, 500g